Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-25 @ 2:29 PM
NCT ID:
NCT04657666
Pre Assignment Details:
Randomized participants completed 2 treatment periods with administration of study drug for 21 days per period. A washout period of at least 7 days separated the 2 treatment periods. During the washout period, participants continued their current MS anti-spasticity medications. Each treatment period included a dose titration phase (\~14 days) followed by a maintenance-dose phase (\~7 days), where the optimized dose level remained unchanged for the remainder of the period after titration.
Recruitment Details:
A total of 68 participants who met all inclusion and no exclusion criteria were randomized to treatment at 9 clinic centers in Poland and 1 center in Czech Republic.
Study:
NCT04657666
Study Brief:
Results Section:
NCT04657666